Project Grant 2321805
Award Date
8/1/23
Completion Date
3/31/24
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Cerflux Inc. (RJKTP1C2LNJ8)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35203, USA
Similar Awards
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Redpoint Oncology, Inc. aims to develop and validate a novel platform for targeted cancer therapies. The project will design and synthesize new "payload" candidates, test their effectiveness and selectivity against therapy-resistant cancer cells, and establish proof-of-concept for this innovative therapeutic approach, which functions similarly to guided...
This National Science Foundation Project Grant of $255,995 supported Encapsulate Inc. to develop an automated biochip platform for personalized cancer screening under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The award period was from May 15, 2022 to April 30, 2023. The platform will grow patient-derived cancer cells outside the body on biochips to screen them against chemotherapy drugs. This addresses the problem that over 70% of cancer patients undergo ineffective...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
This Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,213,619.00 to Encapsulate Inc., a small disadvantaged business, to develop a precision oncology platform that integrates microfluidics, biochips, bioreactors, and 3D tumor models to predict patient-specific cancer drug responses. The project aims to create tumor models from patient-derived biopsy specimens, allowing oncologists to test...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,999 to Therafluor Inc. aims to develop a low-cost multimodal medical instrument for use in veterinary clinics. The instrument will visualize, monitor, and enable the targeted delivery of a proprietary photosensitive compound (silicon naphthalocyanine nanoparticles) to detect and eliminate cancer cells in companion animals. The project seeks to create a new diagnostic and...
The National Science Foundation (NSF) awarded a $206,794 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to The Research Foundation for The State University of New York (RF SUNY) on October 1, 2024. This project aims to develop an innovative artificial intelligence (AI) technology to select optimal treatment options for individual cancer patients, with the goal of prolonging patient life. The project will establish connections with innovation...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $305,000 to Sostos Inc., a minority-owned and woman-owned small business, aims to develop a cloud-based software platform to identify multi-omics biomarkers for guiding non-small cell lung cancer treatment decisions. The proposed technology utilizes advanced AI techniques to model complex molecular interactions and gene regulatory networks, enabling the discovery of biomarkers...
This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant, awarded by the National Science Foundation, focuses on developing 18F-radiotracer kits for the detection of biomarkers using positron emission tomography (PET). The $295,000 award, granted to Theracea Pharma LC, aims to create innovative diagnostic tools to assist researchers and physicians, particularly in the field of oncology. The project leverages advancements in chemistry and biology to design PET diagnostic...
The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical...